Oncology Institute, Inc. (TOIIW) — 10-Q Filings

10-Q Filings (6)

• Oncology Institute's Q3 Loss Narrows Marginally Amid Revenue Surge — Nov 13, 2025 Risk: high
  The Oncology Institute, Inc. (TOIIW) reported a net loss of $16.504 million for the three months ended September 30, 2025, a slight increase from the $16.113 mi
• Oncology Institute's Losses Widen Amid Revenue Growth, Strategic Shift — Aug 13, 2025 Risk: high
  The Oncology Institute, Inc. (TOIIW) reported a net loss of $17.009 million for the three months ended June 30, 2025, an increase from $15.479 million in the pr
• Oncology Institute Files Q1 2025 10-Q — May 14, 2025 Risk: medium
  Oncology Institute, Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as DFP HEALTHCARE ACQUISITIONS CORP., is based in Cerr
• Oncology Institute Files Q3 2024 10-Q — Nov 13, 2024 Risk: medium
  Oncology Institute, Inc. (formerly DFP HEALTHCARE ACQUISITIONS CORP.) filed its 10-Q for the period ending September 30, 2024. The company, located at 18000 Stu
• Oncology Institute, Inc. Files Q2 2024 10-Q — Aug 13, 2024 Risk: medium
  Oncology Institute, Inc. filed its 10-Q for the period ending June 30, 2024. The company, formerly known as DFP Healthcare Acquisitions Corp., is based in Cerri
• Oncology Institute, Inc. Files 10-Q for Period Ending March 31, 2024 — May 14, 2024 Risk: medium
  Oncology Institute, Inc. (TOIIW) filed a Quarterly Report (10-Q) with the SEC on May 14, 2024. Oncology Institute, Inc. filed a 10-Q report for the period endin

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX